A new BMJ study links Ozempic and Mounjaro to 37–68% higher hair loss risk. The FDA is evaluating a safety signal. What patients need to know before their next dose.
Large BMJ Study Confirms GLP-1 Drugs Like Ozempic and Mounjaro Are Linked to a Real Hair Loss Risk
by | Jul 25, 2026 | Uncategorized | 0 comments
Recent Comments